Skip to main content
SpringerLink
Log in

Weichteilsarkome

  • Chapter
Pädiatrische Hämatologie und Onkologie

Part of the book series: Springer Reference Medizin ((SRM))

Zusammenfassung

Weichteilsarkome (WTS) und Weichteiltumoren unterschiedlicher Malignität stellen eine heterogene Gruppe von Tumoren dar, die primär in den Weichteilen entstehen und sich wahrscheinlich aus pluripotenten mesenchymalen Zellen entwickeln. Sie bilden die viertgrößte Gruppe solider Tumoren im Kindesalter. Der häufigste bei Kindern auftretende Tumor aus der Gruppe der WTS ist das Rhabdomyosarkom (RMS). Ziel dieses Kapitels ist es, die Prinzipien der Diagnostik und Behandlung der WTS in den Therapieoptimierungsstudien der GPOH und anderer Studiengruppen darzustellen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Armenian SH et al. (2015) Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 16: e123–e136

    Google Scholar 

  • Arndt CA, Stoner JA, Hawkins DS et al. (2009) Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children’s oncology group study D9803. J Clin Oncol 27: 5182–5188

    Google Scholar 

  • Benesch M, Wardelmann E, Ferrari A et al. (2009) Gastrointestinal stromal tumors (GIST) in children and adolescents: a comprehensive review of the current literature. Pediatr Blood Cancer 53: 1171–1179

    Google Scholar 

  • Breitfeld PP, Lyden E, Raney RB et al. (2001) Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Hematol Oncol 23: 225–233

    Google Scholar 

  • Carli M, Colombatti R, Oberlin O et al. (1999) High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma. J Clin Oncol 17: 2796–2803

    Google Scholar 

  • Carli M, Colombatti R, Oberlin O et al. (2004) European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol 22: 4787–4794

    Google Scholar 

  • Carli M, Ferrari A, Mattke A et al. (2005) Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group. J Clin Oncol 23: 8422–8430

    Google Scholar 

  • Casanova M, Ferrari A, Collini P et al. (2006) Epithelioid sarcoma in children and adolescents: a report from the Italian Soft Tissue Sarcoma Committee. Cancer 106: 708–717

    Google Scholar 

  • Chavez C, Hoffmann MA (2013) Complete remission of ALK-negative plasma cell granuloma (inflammatory myofibroblastic tumor) of the lung induced by celecoxib: a case report and review of the literature. Oncol Lett 5: 1672–1676

    Google Scholar 

  • Coindre JM, Trojani M, Contesso G et al. (1986) Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 58: 306–309

    Google Scholar 

  • Crist WM, Anderson JR, Meza JL et al. (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with non-metastatic disease. J Clin Oncol 19: 3091–3102

    Google Scholar 

  • CWS-Guidance (2014) Version 1.6.1 der CWS-guidance (CWS-guidance for risk adapted treatment of soft tissue sarcoma and soft tissue tumours in children, adolescents and young adults). CWS-Studienzentrale, Stuttgart

    Google Scholar 

  • Dantonello TM, Int-Veen C, Leuschner I et al. (2008) Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups. Cancer 112: 2424–2431

    Google Scholar 

  • Dantonello TM, Int-Veen C, Harms D et al. (2009) Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. J Clin Oncol 27: 1446–1455

    Google Scholar 

  • Dehner LP, Watterson J, Priest J (1995) Pleuropulmonary blastoma. A unique intrathoracic pulmonary neoplasm of childhood. Perspect Pediatr Pathol 18: 214–226

    Google Scholar 

  • Davicioni E, Anderson JR, Buckley JD et al. (2010) Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children’s oncology group. J Clin Oncol 28: 1240–1246

    Google Scholar 

  • Escobar C, Munker R, Thomas JO et al. (2012) Update on desmoid tumors. Ann Oncol 23: 562–569

    Google Scholar 

  • Ferrari A, Chi YY, De Salvo GL etal. (2017) Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children’s Oncology Group. Eur J Cancer 78: 1–6

    Google Scholar 

  • Ferrari A, De Salvo GL, Brennan B etal. (2015) Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005). Ann Oncol 26: 567–572

    Google Scholar 

  • Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) WHO Classification of Tumours of Soft Tissue and Bone, 4th edn. World Health Organization, Genf

    Google Scholar 

  • Grier HE, Krailo MD, Tarbell NJ et al. (2003) Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348: 694–701

    Google Scholar 

  • Hermanek P (1997) International Union Against Cancer: TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumours, 4th edn. Springer, Berlin New York

    Google Scholar 

  • Hill DA, Ivanovich J, Priest JR et al. (2009) DICER1 mutations in familial pleuropulmonary blastoma. Science 325(5943): 965

    Google Scholar 

  • Holtkamp N, Malzer E, Zietsch J et al. (2008) EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy. Neuro Oncol 10: 946–957

    Google Scholar 

  • Jilong Y, Jian W, Xiaoyan Z et al. (2007) Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis. Pathology 39: 319–325

    Google Scholar 

  • Kim A, Widemann BC, Krailo M et al. (2015) Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children’s Oncology Group. Pediatr Blood Cancer 62: 1562–1566

    Google Scholar 

  • Koscielniak E, Harms D, Henze G et al. (1999) Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 17: 3706–3719

    Google Scholar 

  • Koscielniak E, Klingebiel T, Gross-Wieltsch U et al. (2002) Transplantation of a megadose of full-haplotype mismatched hematopoetic stem cell (HSCT) as a treatment of metastatic relapse of Ewing sarcoma. Bone Marrow Transplant 29: 191

    Google Scholar 

  • Koscielniak E, Kosztyla D, Dantonello T et al. (2013) Report of the CWS 2002P study: treatment results for soft tissue sarcomas (STS) in childhood and adolescence. 45th Congress of the International Society of Paediatric Oncology (SIOP) 2013. Hong Kong (China), 25th–28th September 2013. Abstracts. Pediatr Blood Cancer 60 (Suppl 3): 32

    Google Scholar 

  • Kratz CP, Steinemann D, Niemeyer CM et al. (2007) Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome. Hum Mol Genet 16: 374–379

    Google Scholar 

  • Kummar S (2013) Cediranib for metastatic alveolar soft part sarcoma. JClin Oncol 31: 2296–2302

    Google Scholar 

  • Ladra MM, Szymonifka JD, Mahajan A et al. (2014) Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol 32: 3761–3770

    Google Scholar 

  • Mattke AC, Bailey EJ, Schuck A et al. (2009) Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas? Pediatr Blood Cancer 52: 772–776

    Google Scholar 

  • Meazza C, Bisogno G, Gronchi A et al. (2010) Aggressive fibromatosis in children and adolescents: the Italian experience. Cancer 116: 233–240

    Google Scholar 

  • Mentzel T (2010) Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignat mesenchymal tumors of soft tissues. Pathologe 91–96

    Google Scholar 

  • Missiaglia E, Williamson D, Chisholm J et al. (2012) PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J Clin Oncol 30: 1670–1677

    Google Scholar 

  • Mossé YP, Lim MS, Voss SD et al. (2013) Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children’s Oncology Group phase 1 consortium study. Lancet Oncology 14: 472–480

    Google Scholar 

  • Mohajeri A, Tayebwa J, Collin A et al. (2013) Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosomes Cancer 52(10): 873–886

    Google Scholar 

  • Oberlin O, Rey A, Sanchez de Toledo J et al. (2012) Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study. J Clin Oncol 30: 2457–2465

    Google Scholar 

  • Onyango P, Feinberg AP (2011) A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript. Proc Natl Acad Sci 108: 16759–16764

    Google Scholar 

  • Pratt CB, Pappo AS, Gieser P et al. (1999) Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J Clin Oncol 17: 1219

    Google Scholar 

  • Priest JR, Hill DA, Williams GM et al. (2006) Type I pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry. J Clin Oncol 24: 4492–4498

    Google Scholar 

  • Reilly KM (2013) Extending the convergence of canonical WNT signaling and classic cancer pathways for treatment of malignant peripheral nerve sheath tumors. Cancer Discov 3: 610–612

    Google Scholar 

  • Ripperger T, Bielack SS, Borkhardt A et al. (2017) Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A 173: 1017–1037

    Google Scholar 

  • Rosen G, Forscher C, Lowenbraun S et al. (1994) Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer 73: 2506–2511

    Google Scholar 

  • Schuck A, Mattke AC, Schmidt B et al. (2004) Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary? J Clin Oncol 22: 143–149

    Google Scholar 

  • Sparber-Sauer M, Seitz G, Kirsch S et al.; CWS Study Group (2017) The impact of local control in the treatment of type II/III pleuropulmonary blastoma. Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS). J Surg Oncol 115: 164–172

    Google Scholar 

  • Stevens MC, Rey A, Bouvet N et al. (2005) Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology – SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 23: 2618–2628

    Google Scholar 

  • UICC (1982) Union Internationale Contre le Cancer. TNM classification of paedriatric tumours. UICC, Genf

    Google Scholar 

  • Vinod R, Shreyaskumar P (2013) Vascular sarcomas. Curr Oncol Rep 15: 3: 347–355

    Google Scholar 

  • Wachtel M, Runge T, Leuschner I et al. (2006) Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry. J Clin Oncol 24: 816–822

    Google Scholar 

  • Weigel BJ, Breitfeld PP, Hawkins D et al. (2001) Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma. J Pediatr Hematol Oncol 23: 272–276

    Google Scholar 

  • Weigel BJ, Lyden E, Anderson JR et al. (2016) Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group. J Clin Oncol 34: 117–122

    Google Scholar 

  • Worst BC, van Tilburg CM, Balasubramanian GP et al. (2016) Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study. Eur J Cancer 65: 91–101

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pädiatrie 5, Klinikum Stuttgart – Olgahospital, Kriegsbergstr. 62, 70174, Stuttgart, Deutschland

    Prof. Dr. med. E. Koscielniak

  2. Klinik für Kinder- und Jugendmedizin, Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland

    Prof. Dr. med. T. Klingebiel

Authors
  1. Prof. Dr. med. E. Koscielniak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. T. Klingebiel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to E. Koscielniak or T. Klingebiel .

Editor information

Editors and Affiliations

  1. Universitätsklinik um Freiburg Zentrum für Kinder- und Jugendmedizin, Freiburg, Deutschland

    Charlotte Niemeyer

  2. Charité-Universitätsmedizin Berlin, Berlin, Deutschland

    Angelika Eggert

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Koscielniak, E., Klingebiel, T. (2018). Weichteilsarkome. In: Niemeyer, C., Eggert, A. (eds) Pädiatrische Hämatologie und Onkologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43686-8_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-43686-8_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43685-1

  • Online ISBN: 978-3-662-43686-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation